Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Impax Laboratories Inc (NASDAQ:IPXL)

33.35
Delayed Data
As of Apr 29
 -0.82 / -2.40%
Today’s Change
29.66
Today|||52-Week Range
51.42
-22.01%
Year-to-Date

Stock Price Forecast

The 12 analysts offering 12-month price forecasts for Impax Laboratories Inc have a median target of 41.50, with a high estimate of 48.00 and a low estimate of 30.00. The median estimate represents a +24.44% increase from the last price of 33.35.

Analyst Recommendations

The current consensus among 13 polled investment analysts is to Hold stock in Impax Laboratories Inc. This rating has held steady since April, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
$0.39
Sales
$245.8M
Reporting Date
May 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -36.60%
 
 
 
 
 
 
Growthannually 21.34%
 
 
 
 
 
 

Sales

Growthquarterly -12.88%
 
 
 
 
 
 
Growthannually 17.74%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.